Fujirebio and Sysmex Expand CDMO Partnership into the Field of Neurodegenerative Diseases under Their Immunoassay Collaboration
Fujirebio Holdings Inc. President CEO Goki Ishikawa and Sysmex Corporation President Kaoru Asano today announced that they have entered into an agreement to expand their Contract Development and Manufacturing Organization CDMO partnership for Sysmexs Automated Immunoassay System HISCLSeries.